We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Data Science & Analytics/A review on lipid-based nanocarriers mimicking chylomicron and their potential in drug delivery and targeting infectious and cancerous diseases
PeriodicalsData Science & Analytics

A review on lipid-based nanocarriers mimicking chylomicron and their potential in drug delivery and targeting infectious and cancerous diseases

Checking your access to this record.

Abstract & Overview

Abstract Infectious and cancerous diseases are tedious to manage. The problem of drug resistance is often associated with anti-microbial and anti-cancer agents and is one of the most significant challenges that restrict their activity. Therefore, it is necessary to increase doses or drug combinations. However, introducing drugs in this way is often ineffective due to poor solubility, low bioavailability, reduced stability, and different drug pharmacokinetic parameters. Vesicular nanocarriers are considered promising for effective drug delivery and overcoming drug resistance. Lipid-based drug delivery systems (LBDDS) such as emulsomes (EMLs) can solve many problems associated with drug physicochemical properties. EMLs share structural similarities with liposomes and solid lipid nanoparticles (SLNs). The main components of emulsomal preparation are triglycerides (TG), phospholipids (PC), and cholesterol (Chol). These systems provide greater stability and pharmacokinetic parameters in vivo compared to liposomes and other lipid-based systems, overcoming their limitations and surpassing their shortcomings. This review offers a broad summary of emulsomal research to date and a comprehensive overview of the formulation materials and their effects on the fabrication, physical characteristics, surface modification, lymphatic targeting, and recent applications of EMLs in infectious and cancerous diseases. EMLs can offer stable and safe lipid-based systems with adequate entrapment and sustained release properties, improving bioavailability and evading multidrug resistance. Furthermore, they hold promise for future clinical applications for anti-microbial and anti-cancer drugs. Graphical Abstract

Cite this record

Rana E. Elnady, Maha Mohamed Amin, Mohamed Y. Zakaria (2023). A review on lipid-based nanocarriers mimicking chylomicron and their potential in drug delivery and targeting infectious and cancerous diseases. AAPS Open, 9(1). https://doi.org/10.1186/s41120-023-00080-x

Copy in another style

Elnady, R. E., Amin, M. M., & Zakaria, M. Y. (2023). A review on lipid-based nanocarriers mimicking chylomicron and their potential in drug delivery and targeting infectious and cancerous diseases. AAPS Open, 9(1). https://doi.org/10.1186/s41120-023-00080-x
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.